EE392 Number Needed to Treat (NNT) Comparing Sacituzumab Govitecan and Single-Agent Chemotherapy in Relapsed or Refractory Metastatic Triple-Negative Breast Cancer

Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.688
https://www.valueinhealthjournal.com/article/S1098-3015(24)00803-9/fulltext
Title : EE392 Number Needed to Treat (NNT) Comparing Sacituzumab Govitecan and Single-Agent Chemotherapy in Relapsed or Refractory Metastatic Triple-Negative Breast Cancer
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00803-9&doi=10.1016/j.jval.2024.03.688
First page :
Section Title :
Open access? : No
Section Order : 10158
Categories :
Tags :
Regions :
ViH Article Tags :